ImmunityBio (IBRX) Intangibles (2013 - 2024)
ImmunityBio (IBRX) reported Intangibles of $16.1 million for Q2 2024, down 15.45% year-over-year from $19.0 million in Q3 2023, and down 3.1% quarter-over-quarter from $16.6 million in Q1 2024.
ImmunityBio (IBRX) Intangibles (2013 - 2024) Analysis & Trends
ImmunityBio (IBRX) has 11 years of Intangibles data on file, last reported at $16.1 million in Q2 2024.
- Intangibles for Q2 2024 came in at $16.1 million, down 15.45% year-over-year; the trailing twelve-month figure through Jun 2024 was $16.1 million (down 15.45% YoY), and the FY2023 annual result was $17.1 million, down 14.55% from the prior year.
- Intangibles fell to $16.1 million in Q2 2024 per IBRX's latest filing, from $16.6 million in the prior quarter.
- Over five years, Intangibles peaked at $22.3 million in Q1 2022 and troughed at $1.4 million in Q4 2021.
- A 5-year average of $13.2 million and a median of $17.1 million in 2023 frame the typical range for Intangibles.
- The sharpest annual moves came in 2022 and 2024: Intangibles jumped 1454.17% in 2022, then fell 15.45% in 2024.
- A 5-year view of Intangibles shows it stood at $1.5 million in 2020, then decreased by 2.94% to $1.4 million in 2021, then jumped by 1308.66% to $20.0 million in 2022, then dropped by 14.55% to $17.1 million in 2023, then slipped by 6.06% to $16.1 million in 2024.
- Business Quant data shows IBRX's Intangibles at $16.1 million in Q2 2024, $16.6 million in Q1 2024, and $17.1 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4.41 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 30.30 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 418.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 7.73 Mn |
| 10 | ImmunityBio | 7.55 Bn | 7.17 Bn | 43.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 16.06 Mn |
| Mar 31, 2024 | 16.57 Mn |
| Dec 31, 2023 | 17.09 Mn |
| Sep 30, 2023 | 18.47 Mn |
| Jun 30, 2023 | 18.99 Mn |
| Mar 31, 2023 | 19.50 Mn |
| Dec 31, 2022 | 20.00 Mn |
| Sep 30, 2022 | 20.47 Mn |
| Jun 30, 2022 | 21.74 Mn |
| Mar 31, 2022 | 22.35 Mn |
| Dec 31, 2021 | 1.42 Mn |
| Sep 30, 2021 | 1.43 Mn |
| Jun 30, 2021 | 1.45 Mn |
| Mar 31, 2021 | 1.44 Mn |
| Dec 31, 2020 | 1.46 Mn |
| Dec 31, 2018 | 565,000.00 |
| Sep 30, 2018 | 1.13 Mn |
| Jun 30, 2018 | 1.70 Mn |
| Mar 31, 2018 | 2.26 Mn |
| Dec 31, 2017 | 2.83 Mn |